West Pharmaceutical Servs Earnings Conference Call Is Coming Up, Here’s What You Need To Know

West Pharmaceutical Servs (NYSE:WST) will host a conference call at 09:00 AM ET on April 27, 2023, to…

West Pharmaceutical Servs (NYSE:WST) will host a conference call at 09:00 AM ET on April 27, 2023, to discuss Q1 2023 earnings results.

How to Attend West Pharmaceutical Servs (WST) Conference Call

Follow this link to access the live webcast.

To listen to the call, dial +1 864-991-4103 (US) or +1 844-543-0451 (International)

What Is an Earnings Conference Call?

Earnings conference calls allow companies to talk about their recent earnings reports publicly, so that anyone who is interested can get more information on what happened and why it happened.

During a call, a company will discuss future performance expectations as well as go over their quarterly financial results. Most investors have benefitted from listening closely to how management responds to questions, in order to get a feel for how confident they are in the company’s current and future performance.

If you want to take a deeper dive into West Pharmaceutical Servs earnings, you can follow their earnings on Benzinga.

This article was generated by Benzinga’s automated content engine and reviewed by an editor

Total
0
Shares
Related Posts
Read More

What’s Going On With Deckers Outdoor Shares After Earnings?

Deckers Outdoor reported quarterly earnings of $4.95 per share which beat the analyst consensus estimate of $2.90 by 70.69%. Quarterly sales also came in above estimates at $959.758 million. Investors appear to be so enamored with the company's quarterly earnings that they are overlooking the company's fiscal year outlook for earnings of between $29.50 and $30.00 per share, slightly below the $30.29 consensus estimate.

DECK

Read More

BioCardia Earnings Preview

  BioCardia (NASDAQ:BCDA) is set to give its latest quarterly earnings report on Wednesday, 2022-08-10. Here's what investors need to know before the announcement. Analysts estimate that BioCardia will report an earnings per share (EPS) of $-0.25.

BCDA